Jones and Somaiah Review the Rationale and Design of the Peak Trial in GIST

0 ビュー· 09/18/23
OncLive® On Air
OncLive® On Air
0 加入者
0

Drs Jones and Somaiah discuss unmet needs in GIST that the Peak trial seeks to answer; the advantages of the methods and design of this trial; and how the tolerable safety profile of bezuclastinib plus sunitinib supports further research with this combination.

もっと見せる

 0 コメント sort   並び替え


次に